[HTML][HTML] Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection

…, AA Schäffer, E Ruppin, S Vinker, E Magen - Vaccines, 2021 - mdpi.com
Immune protection following either vaccination or infection with SARS-CoV-2 is thought to
decrease over time. We designed a retrospective study, conducted at Leumit Health Services …

Copper oxide impregnated textiles with potent biocidal activities

…, G Borkow, J Mishal, E Magen… - Journal of Industrial …, 2006 - journals.sagepub.com
Impregnation or coating of cotton and polyester fibers with cationic copper endows them with
potent broad-spectrum antibacterial, antiviral, antifungal, and antimite properties (Borkow, G…

Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection: test negative design study

…, I Green, A Golan-Cohen, E Ruppin, E Magen… - bmj, 2021 - bmj.com
Objectives To determine whether time elapsed since the second injection of the Pfizer-BioNTech
BNT162b2 mRNA vaccine was significantly associated with the risk of covid-19 …

COVID-19 susceptibility in bronchial asthma

…, E Merzon, S Vinker, A Golan-Cohen, E Magen - The Journal of Allergy …, 2021 - Elsevier
Background Bronchial asthma has not been adequately assessed in coronavirus disease
2019 (COVID-19). Respiratory allergy is associated with significant reductions in the …

[HTML][HTML] Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection in a large cohort

…, I Green, A Golan-Cohen, E Ruppin, E Magen… - MedRxiv, 2021 - ncbi.nlm.nih.gov
Objective: To determine whether time elapsed since the second BNT162b2 messenger RNA
(mRNA) vaccine (Pfizer-BioNTech) injection is significantly associated with the risk of post-…

[HTML][HTML] Clinical and molecular characterization of a rare case of BNT162b2 mRNA COVID-19 vaccine-associated myositis

E Magen, S Mukherjee, M Bhattacharya, R Detroja… - Vaccines, 2022 - mdpi.com
Initial clinical trials and surveillance data have shown that the most commonly administered
BNT162b2 COVID-19 mRNA vaccine is effective and safe. However, several cases of mRNA …

[HTML][HTML] Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-2

E Magen, A Yakov, I Green, A Israel… - Allergy and Asthma …, 2022 - ncbi.nlm.nih.gov
Background: The factors that trigger and exacerbate chronic spontaneous urticaria (CSU)
are well known, but it is not unclear whether messenger RNA (mRNA) vaccination against …

[HTML][HTML] Helicobacter pylori and skin autoimmune diseases

E Magen, JS Delgado - World journal of gastroenterology: WJG, 2014 - ncbi.nlm.nih.gov
Autoimmune skin diseases are characterized by dysregulation of the immune system
resulting in a loss of tolerance to skin self-antigen (s). The prolonged interaction between the …

The use of aspirin for primary prevention of cardiovascular disease is associated with a lower likelihood of COVID‐19 infection

…, M Frenkel‐Morgenstern, E Magen - The FEBS …, 2021 - Wiley Online Library
Acetylsalicylic acid (aspirin) is commonly used for primary and secondary prevention of
cardiovascular diseases. Aspirin use is associated with better outcomes among COVID‐19 …

Increased mean platelet volume and C-reactive protein levels in patients with chronic urticaria with a positive autologous serum skin test

E Magen, J Mishal, V Feldman, Y Zeldin… - The American journal of …, 2010 - Elsevier
Introduction Activation of the coagulation cascade resulting in thrombin production is a prominent
feature of exacerbations in chronic spontaneous urticaria (CU). Autologous serum skin …